Aldeyra Therapeutics Board of Directors, Key People and Executives

Health Care & Life Sciences » Biotechnology | Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc. | Key People and Executives

Richard H. Douglas

Chairman

Todd C. Brady

President, Chief Executive Officer & Director

Ben R. Bronstein

Independent Director

Neal S. Walker

Independent Director

Gary M. Phillips

Independent Director

Martin Joseph Joyce

Independent Director

Jesse I. Treu

Independent Director

Richard H. Douglas

Chairman

Todd C. Brady

President, Chief Executive Officer & Director

Joshua Reed

Chief Financial Officer

Adnan Halilovic

Manager-Scientific Affairs

David Clark

Chief Medical Officer

David McMullin

Senior VP-Corporate Development & Strategy

Susan G. Macdonald

Vice President-Research & Development

Ben R. Bronstein

Independent Director

Neal S. Walker

Independent Director

Gary M. Phillips

Independent Director

Martin Joseph Joyce

Independent Director

Jesse I. Treu

Independent Director

View Profile

Address	131 Hartwell Avenue Lexington Massachusetts 02421 United States
Employees	-
Website	http://www.aldeyra.com
Updated	07/08/2019
Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. The company was founded by Thomas A.